Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06831084 · ClinicalTrials.gov registry record · NA
Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology
A NA study of Radiation Dermatitis Acute, sponsored by Parul Barry.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06831084 is a NA study of Radiation Dermatitis Acute that is active but no longer recruiting, run by Parul Barry. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06831084, a NA study of Radiation Dermatitis Acute, is active but no longer recruiting, sponsored by Parul Barry.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients who are eligible to receive adjuvant whole breast radiotherapy with or without regional nodal irradiation as part of their care will be included in this study. Patients will use Silver-plated technology (SPT) dressing as directed per user instruction manual and change dressings weekly. Patients will continue to wear the SPT dressing for 2 weeks following completion of RT. The presence and severity of ARD will be recorded at the time of the weekly OTV and at one month after finishing the treatment.
Conditions Studied
Interventions
- DEVICE Silver plated technology (SPT) dressing
Study Locations (1)
Pennsylvania
- UPMC Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-03-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06831084
The ClinicalTrials.gov registry entry for NCT06831084 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Parul Barry, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation Dermatitis Acute appearing as the primary indexed condition, and to 1 intervention - of which Silver plated technology (SPT) dressing is the first listed.
NCT06831084 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06831084 about?
NCT06831084 is a clinical study titled "Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology". Patients who are eligible to receive adjuvant whole breast radiotherapy with or without regional nodal irradiation as part of their care will be included in this study. Patients will use Silver-plated technology (SPT) dressing as directed per user instruction manual and change dressings weekly. Pati...
What is the current status of trial NCT06831084?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2025-05-01. Estimated completion is 2026-03-17.
What conditions does trial NCT06831084 study?
This clinical trial studies the following conditions: Radiation Dermatitis Acute.
What interventions are being tested in trial NCT06831084?
The interventions under investigation include: Silver plated technology (SPT) dressing (DEVICE).
Who is sponsoring clinical trial NCT06831084?
This trial is sponsored by Parul Barry, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06831084 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.